Analysis reveals that antibody fragment-drug conjugates induce immunogenic cell death compared to ADCs, suggesting superior treatment potential.
Supplementary Figure 7 showing evidence of immunogenic cell death (ICD) for FDCs compared to ADCs and control molecules
No takes yet. Share an insight, caveat, or question.
Stamati et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: